PFE
Pfizer Inc.
$24.76
+$0.16(+0.65%)
72
Overall
100
Value
45
Tech
--
Quality
Market Cap
$141.68B
Volume
37.03M
52W Range
$20.92 - $30.43
Target Price
$27.90
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $48.9B | $52.8B | $52.5B | $53.6B | $41.2B | $41.7B | $81.3B | $91.8B | $59.6B | $63.6B | ||
| Total Revenue | $48.9B | $52.8B | $52.5B | $53.6B | $41.2B | $41.7B | $81.3B | $100.3B | $59.6B | $63.6B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $9.6B | $12.3B | $11.2B | $11.2B | $8.3B | $8.5B | $30.8B | $34.3B | $25.0B | $17.9B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $39.2B | $40.5B | $41.3B | $42.4B | $32.9B | $33.2B | $50.5B | $66.0B | $34.6B | $45.8B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $22.5B | $22.7B | $22.5B | $22.5B | $21.1B | $21.0B | $26.5B | $28.7B | $25.6B | $25.7B | ||
| Research & Development | $7.7B | $7.9B | $7.7B | $8.0B | $8.4B | $9.4B | $13.8B | $12.4B | $10.9B | $10.9B | ||
| Research Expense | $7.7B | $7.9B | $7.7B | $8.0B | $8.4B | $9.4B | $10.4B | $11.4B | $10.7B | $10.8B | ||
| Selling, General & Administrative | $14.8B | $14.8B | $14.8B | $14.5B | $12.8B | $11.6B | $12.7B | $13.7B | $14.8B | $14.7B | ||
| Selling & Marketing Expenses | $3.1B | $3.2B | $3.1B | $3.1B | $2.4B | $1.8B | $2.0B | $2.8B | $3.7B | $3.3B | ||
| General & Administrative Expenses | $14.8B | $14.8B | $14.8B | $14.5B | $12.8B | $11.6B | $12.7B | $13.7B | $14.8B | $14.7B | ||
| Promotion & Advertising | $3.1B | $3.2B | $3.1B | $3.1B | $2.4B | $1.8B | $2.0B | -- | -- | -- | ||
| Salaries & Wages | -- | -- | -- | -- | $-137.0M | $-141.0M | $-1.6B | -- | -- | -- | ||
| Depreciation & Amortization | $5.2B | $5.8B | $6.3B | $6.4B | $6.0B | $4.7B | $5.2B | $5.1B | $6.3B | $7.0B | ||
| Depreciation & Amortization | $5.2B | $5.8B | $6.3B | $6.4B | $6.0B | $4.7B | $5.2B | -- | -- | -- | ||
| Amortization | $48.2B | $54.4B | $56.0B | $53.4B | $48.2B | $49.6B | $49.2B | $51.4B | $67.8B | $68.5B | ||
| Other Operating Expenses | $-675.0M | $-489.0M | $-753.0M | $-370.0M | $-383.0M | $-411.0M | $-550.0M | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $16.7B | $17.8B | $18.8B | $19.9B | $11.8B | $12.2B | $23.9B | $31.4B | $-50.6B | $-43.5B | ||
| EBITDA | $15.3B | $15.3B | $19.8B | $19.6B | $18.9B | $13.3B | $30.8B | $39.8B | $7.3B | $15.0B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $1.2B | $1.2B | $1.3B | $1.3B | $1.6B | $1.4B | $1.3B | -- | -- | -- | ||
| Intinc | $471.0M | $470.0M | $391.0M | $333.0M | $225.0M | $73.0M | $36.0M | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-728.0M | $-716.0M | $-879.0M | $-983.0M | $-1.3B | $-1.4B | $-1.3B | $-987.0M | $-585.0M | $-2.5B | ||
| Gain on Sale of Securities | $4.3B | $10.2B | $451.0M | $586.0M | $454.0M | $540.0M | $1.3B | $-1.3B | $1.6B | $1.0B | ||
| Other Income/Expense | $2.9B | $3.7B | $1.4B | $2.1B | $-4.8B | $1.2B | $-4.9B | $-1.6B | $-7.4B | $-4.0B | ||
| Other Special Charges | $-2.9B | $-3.7B | $-1.4B | $-2.1B | $-3.3B | $-1.2B | $4.9B | $8.3B | $7.4B | $4.0B | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $811.0M | $1.2B | $-181.0M | $782.0M | $227.0M | $-6.0M | $741.0M | $882.0M | $2.0B | $2.0B | ||
| Special Income Charges | $-1.6B | $-3.1B | $-798.0M | $-4.1B | $-3.4B | $-1.7B | $-1.0B | $-1.5B | $-5.5B | $-5.9B | ||
| Impairment of Capital Assets | $818.0M | $1.4B | $395.0M | $3.1B | $2.8B | $1.7B | $86.0M | $421.0M | $3.0B | $3.3B | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $10.2B | $9.5B | $13.6B | $13.2B | $13.1B | $8.5B | $25.6B | $34.7B | $1.1B | $8.0B | ||
| Pre-Tax Income | $9.0B | $8.4B | $12.3B | $11.9B | $11.5B | $7.0B | $24.3B | $34.7B | $1.1B | $8.0B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $2.0B | $1.1B | $-9.0B | $706.0M | $618.0M | $370.0M | $1.9B | $3.3B | $-1.1B | $-28.0M | ||
| NET INCOME | ||||||||||||
| Net Income | $7.0B | $7.2B | $21.3B | $11.2B | $16.3B | $9.2B | $22.0B | $31.4B | $2.1B | $8.0B | ||
| Net Income (Continuing Operations) | $7.0B | $7.2B | $21.3B | $11.2B | $16.3B | $9.2B | $22.0B | $31.4B | $2.2B | $8.1B | ||
| Net Income (Discontinued Operations) | $7.0B | $7.2B | $21.3B | $11.2B | $16.3B | $9.2B | $22.0B | $31.4B | $2.1B | $8.0B | ||
| Net Income (Common Stockholders) | $11.8B | $13.0B | $26.4B | $17.1B | $21.3B | $9.2B | $22.0B | $31.4B | $2.1B | $8.0B | ||
| TOTALS | ||||||||||||
| Total Expenses | $32.1B | $35.0B | $33.7B | $33.7B | $29.4B | $29.5B | $57.4B | $63.1B | $50.6B | $43.5B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $6.2B | $6.1B | $6.0B | $5.9B | $5.6B | $5.6B | $5.6B | $5.6B | $5.6B | $5.7B | ||
| Average Shares Outstanding (Diluted) | $6.3B | $6.2B | $6.1B | $6.0B | $5.7B | $5.6B | $5.7B | $5.7B | $5.7B | $5.7B | ||
| Shares Outstanding | $6.2B | $6.0B | $6.0B | $5.6B | $5.5B | $5.6B | $5.6B | $5.6B | $5.6B | $5.7B | ||
| Basic EPS | $1.13 | $1.18 | $3.57 | $1.9 | $2.92 | $1.73 | $3.92 | $5.59 | $0.38 | $1.42 | ||
| Basic EPS (Continuing Operations) | $1.13 | $1.18 | $3.57 | $1.9 | $2.92 | $1.26 | $4 | $5.59 | $0.38 | $1.42 | ||
| Diluted EPS | $1.11 | $1.17 | $3.52 | $1.86 | $2.87 | $1.71 | $3.85 | $5.47 | $0.37 | $1.41 | ||
| Diluted EPS (Continuing Operations) | $1.11 | $1.17 | $3.52 | $1.86 | $2.87 | $1.24 | $3.93 | $5.47 | $0.37 | $1.41 | ||
| Dividend Per Share | -- | $1.2 | $1.28 | $1.36 | $1.46 | $1.53 | $1.57 | $1.6 | $1.64 | $1.69 | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | $2.0M | $2.0M | $1.0M | $1.0M | $1.0M | -- | -- | -- | -- | -- | ||
| Basic Discontinuous Operations | -- | -- | -- | -- | -- | $0.47 | $-0.08 | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | -- | -- | $3.5B | $953.0M | $194.0M | $108.0M | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | -- | $0.47 | $-0.08 | -- | -- | -- | ||
| Earnings from equity interest | $45.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | $45.0M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | -- | -- | -- | $8.1B | $6.0M | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | $52.0M | $71.0M | $32.0M | $-237.0M | $99.0M | -- | -- | -- | ||
| Gains Loss On Disposal Of Discontinued Operations | $-6.0M | $-1.7B | $3.0M | $1.0M | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $-26.0M | $-31.0M | $-47.0M | $-36.0M | $-29.0M | $-36.0M | $-45.0M | $-35.0M | $-39.0M | $-31.0M | ||
| Net Income Discontinuous Operations | $11.0M | $16.0M | $2.0M | $10.0M | $5.4B | $2.5B | $-434.0M | $6.0M | $-15.0M | $11.0M | ||
| Non Recurring Operation Expense | -- | $510.0M | $240.0M | $157.0M | $292.0M | $28.0M | $182.0M | $230.0M | $474.0M | $567.0M | ||
| Other Gain Loss From Disposition Of Discontinued Operations | $17.0M | $16.0M | $-1.0M | $10.0M | $5.4B | $2.5B | $-434.0M | $6.0M | $-15.0M | $11.0M | ||
| Other Gand A | $14.8B | $14.8B | $14.8B | $14.5B | $12.8B | $11.6B | $12.7B | $13.7B | $14.8B | $14.7B | ||
| Other Impairment Of Capital Assets | $323.0M | $869.0M | $337.0M | $3.1B | $2.8B | $1.7B | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $2.0M | $2.0M | $1.0M | $1.0M | $1.0M | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $2.0M | $2.0M | $1.0M | $1.0M | $1.0M | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $243.0M | $292.0M | $314.0M | $301.0M | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | $344.0M | $-1.3B | -- | -- | -- | -- | -- | -- | ||
| Restruct | $811.0M | $1.2B | $-181.0M | $782.0M | $227.0M | $-6.0M | $741.0M | $882.0M | $2.0B | $2.0B | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PFE | $24.76 | +0.7% | 37.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |